Rocky Mountain Cancer Centers

499 East Hampden Avenue
Englewood, Colorado 80113

We've found

1 trials

at this facility

Talazoparib For Neoadjuvant Treatment Of Germline Brca1/2 Mutation Patients With Early Triple-negative Breast Cancer

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Englewood, CO

Use our guide to learn which trials are right for you!